Cardiva VASCADE 6/7F VCS: payments to doctors
Payments that named Cardiva VASCADE 6/7F VCS as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 3,928
- Transactions
- 7,109
- Average per transaction
- $153
The per-transaction average — $153 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,928 providers the average total is $277, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Cardiva Medical, Inc. | $1,061,548 | 97.6% |
| Haemonetics Corporation | $25,728 | 2.4% |